Bulk Drug Imports From China Slow, Shows Data
MUMBAI: There is still some way until India’s dependence on imports of active pharmaceutical ingredients (APIs) and intermediates from China reduces, but the growth rate of imports has come down. While the production-linked incentive (PLI) scheme for bulk drugs (APIs) has boosted local production of some key APIs here, industry insiders say it would take […]
The post Bulk Drug Imports From China Slow, Shows Data first appeared on Latest India news, analysis and reports on IPA Newspack.









